Alnylam, Inceptive ink AI deal potentially worth $2B

Thursday, June 4, 2026Kristin JensenView original

The RNA-focused drugmaker says Inceptive's tools will help prioritize the best development options as well as speed up the research process.

Read the full article on the original site.